Pharmabiz

PCI extends timeline till August 31 for completion of approval process for 2026-27

PCI extends timeline till August 31 for completion of approval process for 2026-27: Gireesh Babu, New Delhi Wednesday, August ...
Pharmabiz

European Commission approves Sanofi’s MenQuadfi for use in infants from age six weeks against invasive meningococcal disease

European Commission approves Sanofi’s MenQuadfi for use in infants from age six weeks against invasive meningococcal disease: Paris Wednesday, August 5, 2026, 09:00 Hrs [IST] Sa ...
Pharmabiz

PMBJP drives a transformative shift in access to affordable, quality medicines: Prof R Raveendra

PMBJP drives a transformative shift in access to affordable, quality medicines: Prof R Raveendra: Nandita Vijayasimha, Bengaluru Wednesday, August 5, 2026, 08:00 Hrs [IST] Pradhan ...
Pharmabiz

Digital infrastructure emerging as a core hospital utility alongside power, water & medical gas: Manik Bahri

Digital infrastructure emerging as a core hospital utility alongside power, water & medical gas: Manik Bahri: Shardul Nautiyal, Mumbai Wednesday, August 5, 2026, 08:00 Hrs [IST] A ...
Pharmabiz

DoP cancels RFP to develop comprehensive logistics plan for pharma and medical devices sector

DoP cancels RFP to develop comprehensive logistics plan for pharma and medical devices sector: Our Bureau, New Delhi Wednesday, August 5, 2026, 08:00 Hrs [IST] The Department of P ...
Opinion
PharmabizOpinion

A GOOD MOVE AGAINST COUNTERFEITERS

Of course, the Ministry has taken a good decision in expanding the ambit of Schedule H2 as there can be no difference of opinion about the fact that proliferation of fake medicines is an alarming ...
Pharmabiz

Chakravarthi AVPS wins CMO Asia Business Leadership & Excellence Award

Chakravarthi AVPS wins CMO Asia Business Leadership & Excellence Award: Our Bureau, Mumbai Tuesday, August 4, 2026, 15:15 Hrs [IST] Hyderabad-based pharmaceutical industry leader ...
Pharmabiz

Medi Assist advances access to cashless healthcare with over 50% of hospital pre-authorisations approved under 5 minutes

Medi Assist advances access to cashless healthcare with over 50% of hospital pre-authorisations approved under 5 minutes: Our Bureau, Bengaluru Tuesday, August 4, 2026, 17:25 Hrs ...
Pharmabiz

Invenio Imaging completes enrollment in ON-SITE study, an AI-based image analysis for lung cancer

Invenio Imaging completes enrollment in ON-SITE study, an AI-based image analysis for lung cancer: San Jose, California Tuesday, August 4, 2026, 16:00 Hrs [IST] Invenio Imaging, a ...
Pharmabiz

Eli Lilly's olomorasib receives US FDA's Breakthrough Therapy designation to treat previously treated KRAS G12C-mutant advanced pancreatic cancer

Eli Lilly's olomorasib receives US FDA's Breakthrough Therapy designation to treat previously treated KRAS G12C-mutant advanced pancreatic cancer: Indianapolis Tuesday, August 4, ...
Pharmabiz

US FDA grants fast track designation to Aravax’s PVX108, a next-generation immunotherapy to treat peanut allergy

US FDA grants fast track designation to Aravax’s PVX108, a next-generation immunotherapy to treat peanut allergy: Melbourne, Australia Tuesday, August 4, 2026, 17:00 Hrs [IST] A ...
Pharmabiz

Encube Ethicals files DRHP with SEBI for Rs. 3,000 crore IPO

Mumbai-based Encube Ethicals Limited has filed its Draft Red Herring Prospectus (DRHP) with capital markets regulator, Securities and Exchange Board of India (SEBI) for its Initial Public Offering ...